An observational study in Hidradenitis Suppurativa and Quality of Life, sponsored by Montefiore Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2023-01-20.
Sponsored by Montefiore Medical Center · Observational
The goal of this study is to get a better understanding of the impact of Hidradenitis Suppurativa (HS) on the quality of life of patients with this condition. Patients with HS will be asked questions about demographics including gender, age, and ethnicity. They will also be asked to complete questionnaires to determine how their skin condition affects their life. Study participation will last for 1 day, with potential for follow-up in the future. We hope this information will help us improve our treatment for this skin condition.
The goal of this study is to get a better understanding of the impact of the skin condition, Hidradenitis Suppurativa, on quality of life function of patients. Patients with HS will be asked questions about demographics including gender, age, and ethnicity. They will also be asked to complete questionnaires to determine how their skin condition affects their life. The questionnaires include Beck Depression Inventory form, which gives us information how you feel about your skin condition and how it changes your mood; Dermatology Life Quality Index (DLQI), which gives us information about how your skin condition affects your quality of life; Skindex, which gives us more specific information about how your skin condition affects your quality of life; SF-36 health survey, which gives us information about your general health status; the Quality of Life Enjoyment and Satisfaction Questionnaire- short form (Q-LES-Q-SF), which gives us information on your enjoyment and satisfaction of your life; and the Employment/Productivity Health Economic Questionnaire, which will give us more information on your work and school status as well as household income. Study participation will last for 1 day, with potential for follow-up in the future. Through potential follow up visits we hope to determine the longitudinal effect of treatment modalities on QoL through future survey performance of the patient cohort. We hope this information will help us improve our treatment for this skin condition.
280 studies on the registry are indexed under Hidradenitis Suppurativa; 85 are open to participants now.
This study's enrollment of 400 is above the median of 165 across 71 observational studies indexed under Hidradenitis Suppurativa.
Browse Hidradenitis Suppurativa studies →Montefiore Medical Center is the lead sponsor of 414 studies on the registry; 69 are open to participants now.
Of its 86 completed or terminated interventional studies of FDA-regulated products, 76 (88%) have results posted.
Counted across the registry records on this site, refreshed daily.
Healthy adults (ages 18-99) who have a diagnosis of HS (as deemed by a physician at the Hidradenitis Suppurativa Treatment Center at Montefiore Medical Center)
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with HS who are eligible to fill out the series of quality of life questionnaires
Dermatology-related quality of life
Quality of life as measured using standardized Dermatology Quality of Life Index
Time frame: Baseline
Presence and severity of depression
Presence and severity of depression as measured using standardized Beck Depression Inventory
Time frame: Baseline
Dermatology-related quality of life
Quality of life as measured using standardized SkinDex questionnaires
Time frame: Baseline
Subject-reported subject health
Subject-reported subject health as measured using standardized SF-36 questionnaires
Time frame: Baseline
Degree of enjoyment and satisfaction experienced by subjects in daily functioning.
Degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning as measured by the standardized Quality of Life Enjoyment and Satisfaction Questionnaire-short form.
Time frame: Baseline
Employment and economic productivity
Self-reported employment and economic productivity as measured by a standardized health economic questionnaire
Time frame: Baseline
Change in quality of life
Change in quality of life as measured using standardized Dermatology Quality of Life Index after treatment initiation
Time frame: At 6 months
Change in presence and severity of depression as measured using standardized Beck Depression Inventory
Change in presence and severity of depression as measured using standardized Beck Depression Inventory after treatment initiation
Time frame: At 6 months
Change in quality of life
Change in quality of life as measured using standardized SkinDex questionnaires after treatment initiation
Time frame: At 6 months
Change in subject-reported subject health
Change in subject-reported subject health as measured using standardized SF-36 questionnaires after treatment initiation
Time frame: At 6 months
Change in degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning
Change in degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning as measured by the standardized Quality of Life Enjoyment and Satisfaction Questionnaire-short form after treatment initiation
Time frame: At 6 months
Change in self-reported employment and economic productivity
Change in self-reported employment and economic productivity as measured by a standardized health economic questionnaire after treatment initiation
Time frame: At 6 months
Plan to share: No — There are no plans to share individual participant data to other researchers
Ran from Apr 2015 to primary completion in Sep 2022, 89 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.